Avid Bioservices Inc (CDMO)

[entdoc]

frustrated, I share your anguish, but not your take on, "To be talking about new trials or indications when the company is at all time lows is ludicrous if you really hold any shares..." I might hold as many shares as anyone on this board, and may have lost as much money here. That said, I am not particularly surprised about the results of an immunostimulant pitted against a solid tumor of measurable size. I've been around the operating room, the clinical scene, and the research lab long enough to know that 1)not all avenues you choose turn out to be the right ones; and 2)not all successful applications of a product are those initially intended. It's research. It's cutting a new road, and it is not cruising on a freeway. Only invest what you can afford to lose, and only in something that makes a lot of sense. I'm a LONG way from writng this company off.